Latest "Urban Health Plan, Inc." News Stories

09:11 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Urban Health Plan, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Urban Health Plan, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Urban Health Plan, Inc. for you to read. Along with our medical data and news we also list Urban Health Plan, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Urban Health Plan, Inc. Companies for you to search.

Showing "Urban Health Plan" News Articles 1–25 of 25,000+

Wednesday 20th March 2019 Reminds Workers to Protect Their Eyes on The Job

Eye Safety Advice for National Workplace Eye Wellness Month Every day, about 2,000 U.S. workers experience a job-related eye injury, one-third requiring care in an emergency room, and many causing temporary or permanent vision loss. To honor March as Workplace Eye Wellness Month, an initiative aimed to raise awareness about eye protection on the job,

DionyMed Brands Inc. Signs Binding Term Sheet to Acquire 1.83 Acre Southern California Cannabis Campus from MMAC

DionyMed Strengthens Distribution and Direct-to-Consumer Platform in the Los Angeles Market DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME), a multi-state cannabis brands platform, announced today it has signed a binding term sheet with MM Esperanza 2 LLC, doing business as “MMAC,” to acquire select MMAC assets (the “Acquisitio...

Washington, Michigan and Wisconsin See Flu Activity Gains

Walgreens Flu Index for week ending March 16, 2019 The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. This press release features multimedia. View the full release here: h...

Trust, Value, Credibility – A Guided Approach to Thought Leadership from PAN Communications

New eBook connects programs to increased share of voice and brand awareness PAN Communications, an integrated marketing and PR agency for B2B tech and healthcare brands, today released its latest eBook titled, “

iVantage Health Analytics Launches Breakthrough Platform to Help Health Systems and Physician Leaders Optimize Medical Group Performance

Physician Enterprise Performance Manager is the Industry’s First Integrated Benchmarking & Performance Management Platform Analyzing Patient Access and Cost Data iVantage Health Analytics, a leading provider of performance management and analytic solutions for hospitals and healthcare systems, announced the launch of a new ...

Microbiome Health Index™ Platform to be Presented at Gut Microbiota for Health Summit 2019

Rebiotix’s prototype index is under development to measure impact of microbiota-based therapeutics on Clostridium difficile infection patient microbiomes Microbiome samples from the Rebiotix Phase 2 clinical trials will be featured as part of the index development. Rebiotix Inc., a Ferring company, will present an...

Pepperdine Graziadio Business School and Dignity Health Global Education Announce Partnership to Offer Online Healthcare Certificate Courses

Pepperdine University Graziadio Business School and Dignity Health Global Education (DHGE) announced today they have formed a partnership

Medina Chiropractor Expands Into A New State Of The Art Multidisciplinary Facility With Provider's Onsite From Chiropractor to Neurosurgeon!

Advanced Spine Joint and Wellness is rapidly expanding into Ohio's only truly muti-disciplined facility. and is now offering in Medina, Ohio Chiropractic's, Sports Medicine, Physical Therapy, Massage Therapy, Non-surgical Spinal Decompression, Robotic Laser Therapy, Weight Loss,and Onsite Orthopedic and Spine Surgeons! Same day appointments, same day imaging and MRI's are available f...

Natreon is Granted a U.S. Patent on its CROMINEX® Product

A new patent has been added to Natreon's clinically studied ingredient, Crominex®3+, as it relates to its cardiovascular health benefits. NEW BRUNSWICK, N.J. (PRWEB) March 20, 2019 Natreon has been granted a U.S. Patent (10,183,047, January 22, 2019) on its Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla and shilajit, that has a synergistic e...

Compulink Previews New User Interface for its Ophthalmology SMART EHR at Retina World

Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will preview the new user interface for its

Private health screening: NHS must not be left to “pick up the pieces,” say LMCs

Private screening providers should be mandated to provide follow-up appointments with patients to discuss abnormal results and should not offload responsibility to the NHS, local medical committees...

ConnectedLife and Ocean Protocol Partner to combat Parkinson's Disease

SINGAPORE, March 20, 2019 /PRNewswire/ -- ConnectedLife and Ocean Protocol announce their partnership to advance Parkinson's Disease diagnosis and treatment with safe sharing of patient-generated data. Ocean Protocol Founder, Trent McConaghy By combining

AdvoCare Donates $10,000 to City of Miami Parks and Recreation - Hosts Tennis Clinic with Pro Cici Bellis

Furthering its mission to help people live healthier lives, AdvoCare is partnering with the City of Miami’s after school program to bring tennis to children in the Shenandoah area AdvoCare International, L.P., a health and wellness company, will host an after-school tennis clinic with AdvoCare endorser and Women’s Tennis Association (WTA) pl...

Researchers and public-health advocates are concerned about the alarming amount of two common antibiotics that will be sprayed over orange orchards this season. They worry that this plan might spur resistance in some human pathogens.

Researchers and public-health advocates are concerned about the alarming amount of two common antibiotics that will be sprayed over orange orchards this season. They worry that this plan might spur resistance in some human pathogens. 

KCU Names Vice Provost for Oral Health Initiatives in Joplin

Kansas City University is committed to establishing a College of Dental Medicine on our Farber-McIntire Campus in Joplin Missouri. We will soon be completing our due diligence process and expect to be making a public announcement shortly. The hiring of Dr. Koelbl, a nationally recognized expert in dental education, is but one step towards the establishment of a world-class College of Dental Medi...

Alliance for Food and Farming: Studies Show “Dirty Dozen” Recommendations Unsupportable, Verify Produce Safety

Since 1995, an activist group has released a so-called “dirty dozen” produce list. However, peer reviewed studies show this list’s recommendations are not scientifically supportable while other studies show it may

One Drop partners with Amazon’s Choice to expand health services offering

Through this partnership, One Drop and Amazon’s Choice will bring affordable, accessible, and comprehensive digital health management services to Amazon’s Choice customers living with diabetes and hypertension nationwide. The post One Drop partners with Amazon’s Choice to expand health services offering appeared first on Compelo Medical Devices - Latest industry news and analysi...

SCWorx Wins State University System Renewal Contract for $427,000

SCWorx Corp (NASDAQ: WORX) today announced the signing of a renewal agreement with an existing Midwestern State University. Initially, the contract was a 1-year fixed-term agreement with the option to renew. This is the second contract renewal totaling $427,000 with this highly respected healthcare provider. The university is utilizing SCWorx’s data norm...

Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases

Eos Biosciences, Inc. (Eos), a nanomedicines company developing an efficient and versatile nanobiologic particle-based platform technology (Eosomes), announced that the U.S. Patent and Trademark Office has granted Eos Biosciences Patent No. 10,183,078, relating to a novel approach of using HER3-targeted Eosomes as a shuttle system for transporting v...

Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022

Collaboration will Continue to Focus on Discovery and Development of Novel Biologic Therapeutics Across a Range of Therapeutic Areas Merck to Return GDF15 Receptor Agonist Program to NGM Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its optio...

On World Oral Health Day, Mercy Ships Recognizes Woodbury, MN Dentist’s Contribution to Dental Professionals and Patients in Guinea

Dr. David Ugai leads Mercy Ships dental team in Guinea, West Africa, teaching 13 dentists and 41 dental students while also providing care to nearly 6,000 patients. GARDEN VALLEY, Texas (PRWEB) March 20, 2019 On World Oral Health Day, Mercy Ships recognizes lead dentist Dr. David Ugai, a volunteer from Woodbury, MN, for his commitment and dedication to the oral health of patients in Africa. Dr. U...

The Center for Advancing Innovation Kicks off THE BRAIN RACE, a Global Contest to Defeat Brain Tumors

Teams, Individuals and Startups Invited to Participate in Competition BETHESDA, Md. (PRWEB) March 20, 2019 The Center for Advancing Innovation (CAI), a global nonprofit that accelerates research commercialization, today launched THE BRAIN RACE, an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors. With support from The Brain Tumour Charity and Resonanc...

Knopp Biosciences Enters Collaboration with Leading UK Investigators to Commence Phase 2 Clinical Trial of Dexpramipexole in Severe Eosinophilic Asthma

Lead investigator Prof. Salman Siddiqui sees potential to provide an alternative to oral steroids or biologic injections for severe asthma patients with high eosinophil counts Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high ...

Imugene’s Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx Immunotherapy Clinical Development Plan

Sydney, Australia – 20 March 2019 – Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, today announced it had received and accepted the minutes of its Pre-Investigational New Drug (IND) meeting with the US Food and Drug Administration (FDA) for its KEY-Vaxx cancer immunotherapy on 8 February 2019. Imugene Managing Director and Chief Executive Officer Leslie Cho...

Merck KGaA, Pfizer discontinue phase III JAVELIN ovarian PARP 100 trial

The alliance has notified health authorities and trial investigators of the decision to discontinue the trial. The decision was based on several emerging factors since the trial’s initiation, The post Merck KGaA, Pfizer discontinue phase III JAVELIN ovarian PARP 100 trial appeared first on Pharmaceutical Business review.

Quick Search


News Quicklinks